Medvest Capital
VC Fund
Palm Beach Gardens, United States
Medvest Capital is a VC fund in Palm Beach Gardens focused on Health Care and Medical Device. Medvest is a mission-driven venture capital firm founded on three core and interrelated principles: Improve Patient Outcomes, Decrease Delivery Costs and Minimize Provider Risk. In addition to providing capital, our team works with portfolio company management to validate market feasibility, fast track product development, and instill the businessprocesses that lead to sustainable growth. Our target investment amount is from $1 million to $3 million.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Medvest Capital invests in
Stages Medvest Capital invests in
Countries Medvest Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
David Cash
|
|||
Investment Focus
Industry
- Health Care 3 (50%)
- Medical Device 3 (50%)
- Medical 2 (33%)
- Analytics 1 (17%)
- Therapeutics 1 (17%)
Stage
- Series C 2 (33%)
- Series D 2 (33%)
- Series B 1 (17%)
- Series E 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
David Cash
Principal
|
Principal | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
BrightSpec
|
LabBrightSpec addresses high-value, time-sensitive analytical chemistry challenges that are not well addressed by other spectroscopy techniques and instruments. It provides innovative laboratory services in order to deliver immediate results to potential customers of our instrumentation products. They are based in Charlottesville, Virginia,about two hours from Washington, DC. The BrightSpec Fourier transform molecular rotational resonance (FT-MRR) product platform is based on technology developed at the University of Virginia by Brooks Pate and his team, several of whom now work at BrightSpec. They offer FT-MRR product configurations for analytical chemistry and gas sensing in manufacturing process control, quality control, environmental monitoring, and formulation research. | $18.4M / Series C / Dec 14, 2022 | |
Osteal Therapeutics
|
Osteal Therapeutics is a clinical-stage specialty pharmaceutical company developing novel drug and device combination products for treating musculoskeletal infection. | $30M / Series B / Dec 29, 2021 | |
Freespira, Inc.
|
Freespira is at the forefront of revolutionizing behavioral healthcare with evidence based, at-home, drug-free solutions. Its flagship product, Freespira®, is the only FDA-cleared digital therapeutic proven to significantly reduce or eliminate panic attacks, panic disorder and PTSD symptoms in 28 days by training users to normalize respiratoryirregularities. | $10M / Series D / Oct 16, 2020 | |
Providence Medical Technology
|
Providence Medical Technology is a privately-held medical device company focused on innovative solutions for cervical spinal conditions. The company has pioneered a proprietary approach to cervical fusion and has developed surgical instrumentation and implants that offer unique benefits to the $2 billion worldwide cervical spine market. TheProvidence family of products includes the DTRAX® Spinal Instrumentation System, CAVUX® intervertebral implants, and the ALLY® line of bone and facet screws. All products are shipped-sterile and single-use to maximize perioperative efficiency and ensure consistent quality and performance. | $10.5M / Series E / Dec 19, 2016 | |
|
Providence Medical Technology
|
Providence Medical Technology is a privately-held medical device company focused on innovative solutions for cervical spinal conditions. The company has pioneered a proprietary approach to cervical fusion and has developed surgical instrumentation and implants that offer unique benefits to the $2 billion worldwide cervical spine market. TheProvidence family of products includes the DTRAX® Spinal Instrumentation System, CAVUX® intervertebral implants, and the ALLY® line of bone and facet screws. All products are shipped-sterile and single-use to maximize perioperative efficiency and ensure consistent quality and performance. | $12M / Series D / Aug 26, 2015 | |
|
Providence Medical Technology
|
Providence Medical Technology is a privately-held medical device company focused on innovative solutions for cervical spinal conditions. The company has pioneered a proprietary approach to cervical fusion and has developed surgical instrumentation and implants that offer unique benefits to the $2 billion worldwide cervical spine market. TheProvidence family of products includes the DTRAX® Spinal Instrumentation System, CAVUX® intervertebral implants, and the ALLY® line of bone and facet screws. All products are shipped-sterile and single-use to maximize perioperative efficiency and ensure consistent quality and performance. | $6.8M / Series C / Mar 31, 2014 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Medvest Capital invest in?
Medvest Capital invests primarily in Health Care, Medical Device and Medical startups, most often at Series C and Series D stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Medvest Capital?
Public channels for Medvest Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Medvest Capital?
The team at Medvest Capital includes David Cash (Principal). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
